218 related articles for article (PubMed ID: 20080729)
1. Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.
Johnson DJ; Langdown J; Huntington JA
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):645-50. PubMed ID: 20080729
[TBL] [Abstract][Full Text] [Related]
2. Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.
Vadivel K; Schreuder HA; Liesum A; Schmidt AE; Goldsmith G; Bajaj SP
J Thromb Haemost; 2019 Apr; 17(4):574-584. PubMed ID: 30725510
[TBL] [Abstract][Full Text] [Related]
3. Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.
Hopfner KP; Lang A; Karcher A; Sichler K; Kopetzki E; Brandstetter H; Huber R; Bode W; Engh RA
Structure; 1999 Aug; 7(8):989-96. PubMed ID: 10467148
[TBL] [Abstract][Full Text] [Related]
4. Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
Izaguirre G; Aguila S; Qi L; Swanson R; Roth R; Rezaie AR; Gettins PG; Olson ST
J Biol Chem; 2014 Dec; 289(49):34049-64. PubMed ID: 25331949
[TBL] [Abstract][Full Text] [Related]
5. Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.
Yang L; Manithody C; Qureshi SH; Rezaie AR
J Biol Chem; 2010 Sep; 285(37):28488-95. PubMed ID: 20628058
[TBL] [Abstract][Full Text] [Related]
6. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
Brandstetter H; Bauer M; Huber R; Lollar P; Bode W
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9796-800. PubMed ID: 7568220
[TBL] [Abstract][Full Text] [Related]
7. Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa.
Neuenschwander PF
Biochemistry; 2004 Mar; 43(10):2978-86. PubMed ID: 15005634
[TBL] [Abstract][Full Text] [Related]
8. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
Westmark PR; Tanratana P; Sheehan JP
J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
[TBL] [Abstract][Full Text] [Related]
9. Localization of the heparin binding exosite of factor IXa.
Yang L; Manithody C; Rezaie AR
J Biol Chem; 2002 Dec; 277(52):50756-60. PubMed ID: 12397068
[TBL] [Abstract][Full Text] [Related]
10. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
Fang H; Zögg T; Brandstetter H
FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
[TBL] [Abstract][Full Text] [Related]
11. Allosteric activation of antithrombin critically depends upon hinge region extension.
Langdown J; Johnson DJ; Baglin TP; Huntington JA
J Biol Chem; 2004 Nov; 279(45):47288-97. PubMed ID: 15326167
[TBL] [Abstract][Full Text] [Related]
12. Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa.
Yang L; Manithody C; Olson ST; Rezaie AR
J Biol Chem; 2003 Jul; 278(27):25032-8. PubMed ID: 12721300
[TBL] [Abstract][Full Text] [Related]
13. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
[TBL] [Abstract][Full Text] [Related]
14. The Interaction of Factor Xa and IXa with Non-Activated Antithrombin in Michaelis Complex: Insights from Enhanced-Sampling Molecular Dynamics Simulations.
Balogh G; Bereczky Z
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238665
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
[TBL] [Abstract][Full Text] [Related]
16. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
Yuan QP; Walke EN; Sheehan JP
Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.
Qureshi SH; Yang L; Rezaie AR
Thromb Haemost; 2012 Dec; 108(6):1154-64. PubMed ID: 23014580
[TBL] [Abstract][Full Text] [Related]
18. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
Dementiev A; Petitou M; Herbert JM; Gettins PG
Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268
[TBL] [Abstract][Full Text] [Related]
19. Dramatic enhancement of the catalytic activity of coagulation factor IXa by alcohols.
Sturzebecher J; Kopetzki E; Bode W; Hopfner KP
FEBS Lett; 1997 Jul; 412(2):295-300. PubMed ID: 9256238
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
